ACXP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Acurx Pharmaceuticals Inc (ACXP) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows bearish technical indicators, lacks positive catalysts, and has weak financial performance. Additionally, there are no strong trading signals or significant institutional or insider activity to support a buy decision.
The stock is in a bearish trend with MACD histogram at -0.0161 (negatively expanding), RSI_6 at 17.271 (oversold), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is below key support levels, with S1 at 1.942 and S2 at 1.785.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress. No AI Stock Picker or SwingMax signals.
also declined by -1.54%.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$1,992,790 (-29.37% YoY), and EPS declined to -1.23 (-64.35% YoY). Gross margin remained at 0.
No analyst rating or price target changes available for ACXP.
